These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 10626797)
1. Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Mahotka C; Wenzel M; Springer E; Gabbert HE; Gerharz CD Cancer Res; 1999 Dec; 59(24):6097-102. PubMed ID: 10626797 [TBL] [Abstract][Full Text] [Related]
2. Differential subcellular localization of functionally divergent survivin splice variants. Mahotka C; Liebmann J; Wenzel M; Suschek CV; Schmitt M; Gabbert HE; Gerharz CD Cell Death Differ; 2002 Dec; 9(12):1334-42. PubMed ID: 12478470 [TBL] [Abstract][Full Text] [Related]
3. Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas. Suga K; Yamamoto T; Yamada Y; Miyatake S; Nakagawa T; Tanigawa N Oncol Rep; 2005 May; 13(5):891-7. PubMed ID: 15809755 [TBL] [Abstract][Full Text] [Related]
4. Exonization of Alu-generated splice variants in the survivin gene of human and non-human primates. Mola G; Vela E; Fernández-Figueras MT; Isamat M; Muñoz-Mármol AM J Mol Biol; 2007 Mar; 366(4):1055-63. PubMed ID: 17204284 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance and different properties of survivin splicing variants in gastric cancer. Meng H; Lu C; Mabuchi H; Tanigawa N Cancer Lett; 2004 Dec; 216(2):147-55. PubMed ID: 15533590 [TBL] [Abstract][Full Text] [Related]
6. Differential expression of survivin and its splice variants, survivin-DeltaEx3 and survivin-2B, in bladder cancer. Atlasi Y; Mowla SJ; Ziaee SA Cancer Detect Prev; 2009; 32(4):308-13. PubMed ID: 19186007 [TBL] [Abstract][Full Text] [Related]
7. Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer. Végran F; Boidot R; Oudin C; Defrain C; Rebucci M; Lizard-Nacol S Oncogene; 2007 Jan; 26(2):290-7. PubMed ID: 16847456 [TBL] [Abstract][Full Text] [Related]
8. Distinct expression of Survivin splice variants in breast carcinomas. Vegran F; Boidot R; Oudin C; Riedinger JM; Lizard-Nacol S Int J Oncol; 2005 Oct; 27(4):1151-7. PubMed ID: 16142334 [TBL] [Abstract][Full Text] [Related]
9. Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression. Krieg A; Mahotka C; Krieg T; Grabsch H; Müller W; Takeno S; Suschek CV; Heydthausen M; Gabbert HE; Gerharz CD Br J Cancer; 2002 Mar; 86(5):737-43. PubMed ID: 11875736 [TBL] [Abstract][Full Text] [Related]
10. Characterization of an anti-apoptotic glycoprotein encoded by Kaposi's sarcoma-associated herpesvirus which resembles a spliced variant of human survivin. Wang HW; Sharp TV; Koumi A; Koentges G; Boshoff C EMBO J; 2002 Jun; 21(11):2602-15. PubMed ID: 12032073 [TBL] [Abstract][Full Text] [Related]
11. An alternatively spliced survivin variant is positively regulated by p53 and sensitizes leukemia cells to chemotherapy. Zhu N; Gu L; Findley HW; Li F; Zhou M Oncogene; 2004 Sep; 23(45):7545-51. PubMed ID: 15334064 [TBL] [Abstract][Full Text] [Related]
12. Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies. Caldas H; Honsey LE; Altura RA Mol Cancer; 2005 Mar; 4(1):11. PubMed ID: 15743529 [TBL] [Abstract][Full Text] [Related]
13. The cancer antiapoptosis mouse survivin gene: characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression. Li F; Altieri DC Cancer Res; 1999 Jul; 59(13):3143-51. PubMed ID: 10397257 [TBL] [Abstract][Full Text] [Related]
15. An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin. Hirohashi Y; Torigoe T; Maeda A; Nabeta Y; Kamiguchi K; Sato T; Yoda J; Ikeda H; Hirata K; Yamanaka N; Sato N Clin Cancer Res; 2002 Jun; 8(6):1731-9. PubMed ID: 12060610 [TBL] [Abstract][Full Text] [Related]
16. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma. Shiina H; Igawa M; Breault J; Ribeiro-Filho L; Pookot D; Urakami S; Terashima M; Deguchi M; Yamanaka M; Shirai M; Kaneuchi M; Kane CJ; Dahiya R Clin Cancer Res; 2003 Jun; 9(6):2121-32. PubMed ID: 12796377 [TBL] [Abstract][Full Text] [Related]
17. CRM1-mediated nuclear export determines the cytoplasmic localization of the antiapoptotic protein Survivin. Rodríguez JA; Span SW; Ferreira CG; Kruyt FA; Giaccone G Exp Cell Res; 2002 Apr; 275(1):44-53. PubMed ID: 11925104 [TBL] [Abstract][Full Text] [Related]
18. Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas. Mahotka C; Krieg T; Krieg A; Wenzel M; Suschek CV; Heydthausen M; Gabbert HE; Gerharz CD Int J Cancer; 2002 Jul; 100(1):30-6. PubMed ID: 12115583 [TBL] [Abstract][Full Text] [Related]
19. Differential expression of survivin splice isoforms in medulloblastomas. Li XN; Shu Q; Su JM; Adesina AM; Wong KK; Perlaky L; Antalffy BA; Blaney SM; Lau CC Neuropathol Appl Neurobiol; 2007 Feb; 33(1):67-76. PubMed ID: 17239009 [TBL] [Abstract][Full Text] [Related]
20. Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma. Griffith TS; Fialkov JM; Scott DL; Azuhata T; Williams RD; Wall NR; Altieri DC; Sandler AD Cancer Res; 2002 Jun; 62(11):3093-9. PubMed ID: 12036919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]